Higher Framingham steatosis index is associated with prevalent breast cancer in women: cross-sectional evidence from NHANES 1999–2018 and an exploratory hospital-based dataset - Quiz - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Association of Elevated Framingham Steatosis Index with Existing Breast Cancer in Women: Insights from NHANES 1999–2018 and a Supplementary Hospital Dataset

  • By

  • Shuling Tang

  • Yong Mo

  • Tiansheng Su

  • Guangxiang Huang

  • Jiachao Lu

  • Jianbin Bi

  • Hui Li

  • Ligen Mo

  • Jun Yan

  • July 8, 2026

Share

Original Source(s)

Higher Framingham steatosis index is associated with prevalent breast cancer in women: cross-sectional evidence from NHANES 1999–2018 and an exploratory hospital-based dataset

  • by Shuling Tang, Yong Mo, Tiansheng Su, Guangxiang Huang, Jiachao Lu, Jianbin Bi, Hui Li, Ligen Mo, Jun Yan

  • July 8, 2026

Related Content

Development and validation of a multimodality radiomics-based nomogram for predicting HER2 expression status in invasive breast cancer

Molecular characteristics and advances in precision therapeutics for HR-positive and HER2-low breast cancer

Gastrointestinal toxicity associated with cyclin-dependent kinase 4/6 inhibitors in breast cancer patients: insights from a real-world pharmacovigilance analysis